Assessment of Tumor Cell Invasion and Radiotherapy Response in Experimental Glioma by Magnetic Resonance Elastography
Journal of Magnetic Resonance Imaging · 2025
DOI: 10.1002/jmri.29567 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Hannah Fels-Palesandro und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany. Hauptthemen laut MEDLINE: Glioma, Elasticity Imaging Techniques, Brain Neoplasms, Magnetic Resonance Imaging. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Olympia-Morata program of the Medical Faculty, University of Heidelberg, ITMO Cancer Aviesan ISMRM Cancer 2020 grant.
Abstract (Originalsprache)
Background
Gliomas are highly invasive brain neoplasms. MRI is the most important tool to diagnose and monitor glioma but has shortcomings. In particular, the assessment of tumor cell invasion is insufficient. This is a clinical dilemma, as recurrence can arise from MRI‐occult glioma cell invasion. Hypothesis Tumor cell invasion, tumor growth and radiotherapy alter the brain parenchymal microstructure and thus are assessable by diffusion tensor imaging (DTI) and MR elastography (MRE). Study Type Experimental, animal model. Animal Model Twenty‐three male NMRI nude mice orthotopically implanted with S24 patient‐derived glioma cells (experimental mice) and 9 NMRI nude mice stereotactically injected with 1 μL PBS (sham‐injected mice). Field Strength/Sequence 2D and 3D T2‐weighted rapid acquisition with refocused echoes (RARE), 2D echo planar imaging (EPI) DTI, 2D multi‐slice multi‐echo (MSME) T2 relaxometry, 3D MSME MRE at 900 Hz acquired at 9.4 T (675 mT/m gradient strength). Assessment Longitudinal 4‐weekly imaging was performed for up to 4 months. Tumor volume was assessed in experimental mice (n = 10 treatment‐control, n = 13 radiotherapy). The radiotherapy subgroup and 5 sham‐injected mice underwent irradiation (3 × 6 Gy) 9 weeks post‐implantation/sham injection. MRI‐/MRE‐parameters were assessed in the corpus callosum and tumor core/injection tract. Imaging data were correlated to light sheet microscopy (LSM) and histology. Statistical Tests Paired and unpaired t ‐tests, a P ‐value ≤0.05 was considered significant.
Results
From week 4 to 8, a significant callosal stiffening (4.44 ± 0.22 vs. 5.31 ± 0.29 kPa) was detected correlating with LSM‐proven tumor cell invasion. This was occult to all other imaging metrics. Histologically proven tissue destruction in the tumor core led to an increased T2 relaxation time (41.65 ± 0.34 vs. 44.83 ± 0.66 msec) and ADC (610.2 ± 12.27 vs. 711.2 ± 13.42 × 10 −6 mm 2 /s) and a softening (5.51 ± 0.30 vs. 4.24 ± 0.29 kPa) from week 8 to 12. Radiotherapy slowed tumor progression. Data Conclusion MRE is promising for the assessment of key glioma characteristics. Evidence Level NA Technical Efficacy Stage 2
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
- Clinical Cooperation Unit Translational Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Department of Neurology and National Center for Tumor Disease (NCT), Heidelberg University Hospital, Heidelberg, Germany.
- Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
ORCID-Profile: Hannah Fels-Palesandro, Michael O Breckwoldt, Katharina Schregel
Förderung
- Deutsche Forschungsgemeinschaft
- Olympia-Morata program of the Medical Faculty, University of Heidelberg
- ITMO Cancer Aviesan ISMRM Cancer 2020 grant
- Daimler und Benz Stiftung
- European Union's Horizons TMA MSCA Postdoctoral Fellowship Award
- Clinician-Scientist-Program of the University of Heidelberg
Zitieren
APA
Fels-Palesandro, H., Heuer, S., Boztepe, B., Streibel, Y., Ungermann, J., Pan, C., Scheck, J. G., Fischer, M., Sturm, V. J., Azorín, D. D., Karimian-Jazi, K., Annio, G., Abdollahi, A., Weidenfeld, I., Wick, W., Venkataramani, V., Heiland, S., Winkler, F., Bendszus, M., …, & Schregel, K. (2025). Assessment of Tumor Cell Invasion and Radiotherapy Response in Experimental Glioma by Magnetic Resonance Elastography. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29567
Vancouver
Fels-Palesandro H, Heuer S, Boztepe B, Streibel Y, Ungermann J, Pan C, et al. Assessment of Tumor Cell Invasion and Radiotherapy Response in Experimental Glioma by Magnetic Resonance Elastography. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.29567
BibTeX
@article{FelsPalesandro2025,
author = {Fels-Palesandro, Hannah and Heuer, Sophie and Boztepe, Berin and Streibel, Yannik and Ungermann, Johannes and Pan, Chenchen and Scheck, Jonas G and Fischer, Manuel and Sturm, Volker J and Azorín, Daniel D and Karimian-Jazi, Kianush and Annio, Giacomo and Abdollahi, Amir and Weidenfeld, Ina and Wick, Wolfgang and Venkataramani, Varun and Heiland, Sabine and Winkler, Frank and Bendszus, Martin and Sinkus, Ralph and Breckwoldt, Michael O and Schregel, Katharina},
title = {Assessment of Tumor Cell Invasion and Radiotherapy Response in Experimental Glioma by Magnetic Resonance Elastography},
journal = {Journal of Magnetic Resonance Imaging},
year = {2025},
doi = {10.1002/jmri.29567}
}
EUVIMED